Surgery Partners, Inc. (NASDAQ:SGRY) CEO Jason Eric Evans Sells 26,520 Shares

Surgery Partners, Inc. (NASDAQ:SGRY) CEO Jason Eric Evans sold 26,520 shares of the business’s stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.65, for a total value of $680,238.00. Following the transaction, the chief executive officer now owns 560,698 shares in the company, valued at $14,381,903.70. The trade was a 4.52 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY opened at $25.58 on Tuesday. The company has a 50-day simple moving average of $21.84 and a 200-day simple moving average of $26.93. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The company has a market cap of $3.25 billion, a PE ratio of -53.29, a price-to-earnings-growth ratio of 17.77 and a beta of 2.60. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $35.29.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $770.40 million during the quarter, compared to analysts’ expectations of $768.99 million. During the same period in the previous year, the firm posted $0.15 earnings per share. The firm’s revenue was up 14.3% on a year-over-year basis. On average, equities analysts anticipate that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.

Analyst Ratings Changes

SGRY has been the topic of a number of analyst reports. Macquarie restated an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a research note on Tuesday, November 19th. JPMorgan Chase & Co. dropped their target price on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd. Bank of America initiated coverage on Surgery Partners in a research note on Monday, December 16th. They issued a “buy” rating and a $30.00 price objective for the company. Royal Bank of Canada reduced their price objective on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday, November 20th. Finally, UBS Group began coverage on Surgery Partners in a report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $36.56.

Hedge Funds Weigh In On Surgery Partners

Institutional investors have recently added to or reduced their stakes in the business. KBC Group NV lifted its holdings in shares of Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after acquiring an additional 576 shares during the period. Point72 Asia Singapore Pte. Ltd. increased its position in Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock worth $124,000 after purchasing an additional 3,379 shares during the last quarter. Creative Planning purchased a new position in Surgery Partners during the third quarter worth approximately $258,000. Versor Investments LP acquired a new position in shares of Surgery Partners in the 3rd quarter valued at $271,000. Finally, MeadowBrook Investment Advisors LLC grew its stake in shares of Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after buying an additional 1,460 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.